Related content

Co-Expression of Recombinant Human CYP2C9 with Human Cytochrome P450 Reductase in Protease Deficient S. cerevisiae Strain at a Higher Scale Yields an Enzyme of Higher Specific Activity

By  

Drug Metabolism Letters, Vol. 4, Iss. 4, 2010-12 ,pp. : 246-253

Bentham Science Publishers

Access to resources Recommend Favorite

Transcriptional Regulation of CYP2C19 and its Role in Altered Enzyme Activity

By  

Current Drug Metabolism, Vol. 13, Iss. 8, 2012-10 ,pp. : 1196-1204

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction Between Clopidogrel and Proton Pump Inhibitors: Hypothesis to Explain Multifactorial CYP2C19 Inhibition

By  

Drug Metabolism Letters, Vol. 3, Iss. 4, 2009-12 ,pp. : 287-289

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of Enzyme Kinetic Parameters Obtained In Vitro for Reactions Mediated by Human CYP2C Enzymes Including Major CYP2C9 Variants

By  

Current Drug Metabolism, Vol. 11, Iss. 2, 2010-02 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

1-[(Benzofuran-2-yl) phenylmethyl] triazoles as steroidogenic inhibitors: synthesis and in vitro inhibition of human placental CYP19 aromatase

By Vinh T.K.   Yee S.W.   Kirby1 A.J.   Nicholls1 P.J.   Simons C.  

Anti-Cancer Drug Design, Vol. 16, Iss. 4, 2001-08 ,pp. : 217-225

Cognizant Communication Corporation

Access to resources Recommend Favorite